Generated by GPT-5-mini| GT-B fold | |
|---|---|
| Name | GT-B fold |
| Caption | Schematic representation of a two-domain glycosyltransferase fold |
GT-B fold The GT-B fold describes a common two-domain architecture found in a large class of glycosyltransferase proteins that catalyze saccharide transfer reactions. Proteins adopting this architecture are widespread across Bacteria, Archaea, and Eukaryota, and participate in biosynthetic pathways linked to cell-surface glycans, N-linked glycosylation, and secondary metabolites. Structural characterization of GT-B enzymes has informed drug discovery efforts in antibiotic development, vaccine antigen design, and metabolic engineering in Escherichia coli and Saccharomyces cerevisiae.
GT-B enzymes consist of two Rossmann-like domains connected by a flexible linker; they are distinguished from other glycosyltransferase folds by their domain arrangement and active-site localization at the interdomain cleft. Crystal structures solved by groups at institutions such as the Protein Data Bank contributors and laboratories affiliated with the European Molecular Biology Laboratory and National Institutes of Health revealed conserved topologies despite low sequence identity. GT-B proteins are cataloged in resources developed by the CAZy consortium and analyzed in comparative studies by teams at the European Bioinformatics Institute and Max Planck Society.
The fold is characterized by two α/β/α Rossmann-like domains with βαβ motifs and parallel β-sheets, producing a deep cleft that binds nucleotide sugars and acceptors. High-resolution structures determined using synchrotron beamlines at facilities like Diamond Light Source and Advanced Photon Source show conserved hydrophobic cores and varying loop conformations. Key structural studies published in journals associated with the Nature Publishing Group and American Chemical Society demonstrate how domain closure, mediated by hinge residues often conserved across families, organizes the catalytic geometry.
Catalysis typically involves in-line or retaining glycosyl transfer, with the nucleotide-donor bound in the C-terminal domain and acceptor positioned by the N-terminal domain; transition-state stabilization uses residues contributed by both domains. Mechanistic insights refined by kinetic analyses in laboratories at the University of Cambridge and computational studies from the Massachusetts Institute of Technology implicate conserved acidic or basic side chains and ordered water networks in proton shuttling. Structural snapshots of donor and acceptor complexes solved by teams at the Max Planck Institute for Biophysical Chemistry and the University of Oxford elucidate variations in substrate-assisted catalysis and metal ion dependence in select families.
GT-B enzymes are grouped into multiple glycosyltransferase families defined by sequence and structural motifs in the CAZy database; prominent families include those involved in O-antigen assembly, peptidoglycan modification, and small-molecule glycosylation. Comparative phylogenetic analyses performed at the University of California, San Diego and Harvard University connect GT-B families to biosynthetic clusters characterized at the Joint Genome Institute. Representative members studied in depth include enzymes from pathogenic genera such as Pseudomonas and Streptococcus, industrial microbes like Corynebacterium glutamicum, and eukaryotic enzymes from Homo sapiens implicated in congenital disorders.
GT-B glycosyltransferases participate in synthesis of lipopolysaccharide O-antigens, antibiotic glycosides, glycoprotein glycans, and plant secondary metabolites; examples include synthesis enzymes from Mycobacterium tuberculosis involved in cell-envelope biogenesis and flavonoid glycosyltransferases characterized in Arabidopsis thaliana. Functional studies combining genetics at institutions such as the Wellcome Sanger Institute and biochemical assays from the John Innes Centre have linked GT-B activity to virulence, immunogenicity, and environmental adaptation. Structural and mutational work on enzymes from Bacillus subtilis and Streptomyces species has enabled engineering of substrate specificity for biotechnological applications pursued by groups at Imperial College London and industrial partners.
Evolutionary analyses using approaches developed at the European Molecular Biology Laboratory and phylogenomics frameworks from the National Center for Biotechnology Information suggest GT-B families evolved via gene duplication, domain shuffling, and horizontal transfer among bacterial lineages. Molecular dynamics simulations run on supercomputers at the Oak Ridge National Laboratory and the Swiss National Supercomputing Centre illuminate domain-closing motions, allosteric effects, and conformational selection mechanisms that underlie substrate recognition. Comparative structural studies across taxa reported by researchers at the Max Planck Society and University of Tokyo show conserved cores with variable surface loops that tune specificity.
Investigation integrates X-ray crystallography, cryogenic electron microscopy at facilities like the European Synchrotron Radiation Facility, NMR spectroscopy from groups at the Riken institute, enzymology, and in silico docking using tools developed at Stanford University and University of California, Berkeley. Applications include rational design of glycosyltransferase inhibitors for Mycobacterium tuberculosis drug discovery, glycoengineering of therapeutic proteins in CHO cells for biopharmaceuticals, and synthetic biology approaches in Escherichia coli to produce glycosylated natural products. Collaborative initiatives between academia and industry, exemplified by partnerships involving the Bill & Melinda Gates Foundation and pharmaceutical companies, leverage GT-B structural knowledge for vaccine and antibiotic development.
Category:Glycosyltransferases